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**Additional file 1.** Study protocol.
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The protocol was conceived and drafted by LPM & POR, and all authors were involved in review, amendments, and approval of the final protocol. POR had primary responsibility for statistical methodology. The authors read and approved the final manuscript.

There is no funder for this study. There has been no involvement of funding sources in the study design; in the collection, analysis, and interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication.

The data will be available from the author on reasonable request. Please contact the corresponding author Dr Pablo O. Rodriguez (prodriguez\@cemic.edu.ar).

The protocol was evaluated by the Local Research Ethics Committee of CEMIC (Buenos Aires, Argentina), on May 13, 2020 with the reference code 1264. It was approved on May 13, 2020.

Patient's next of kin will be asked for informed consent. This will be reflected in the medical record before included in the clinical trial. A copy of the informed consent will be attached in the medical record.
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